Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

PartGerick Wilson

Department of Pharmacology, University of Otago, New Zealand
Publications

Redefining Drug Development: Artificial Intelligence's Part Redefining Drug Development: Artificial Intelligence

Artificial intelligence (AI) has emerged as a transformative force in the field of drug discovery, revolutionizing traditional approaches and expediting the development of novel therapeutics. This abstract explores the pivotal role of AI in various stages of drug discovery, including target identification, compound design, virtual screening, predic... Read More»

PartGerick Wilson

: J Pharmacokinet Exp Ther

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top